CA2404233A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer Download PDF

Info

Publication number
CA2404233A1
CA2404233A1 CA002404233A CA2404233A CA2404233A1 CA 2404233 A1 CA2404233 A1 CA 2404233A1 CA 002404233 A CA002404233 A CA 002404233A CA 2404233 A CA2404233 A CA 2404233A CA 2404233 A1 CA2404233 A1 CA 2404233A1
Authority
CA
Canada
Prior art keywords
seq
sequence
cdna sequence
polypeptide
determined cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002404233A
Other languages
English (en)
French (fr)
Inventor
Steven G. Reed
Michael J. Lodes
Raodoh Mohamath
Heather Secrist
Darin R. Benson
Carol Yoseph Indirias
Robert A. Henderson
Steven P. Fling
Paul A. Algate
Mark Elliot
Jane Mannion
Michael D. Kalos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Individual filed Critical Individual
Publication of CA2404233A1 publication Critical patent/CA2404233A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002404233A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer Abandoned CA2404233A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US09/538,037 2000-03-29
US58893700A 2000-06-05 2000-06-05
US09/588,937 2000-06-05
US64087800A 2000-08-18 2000-08-18
US09/640,878 2000-08-18
US09/667,170 2000-09-20
US23451700P 2000-09-22 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/704,512 2000-11-01
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer
US09/738,973 2000-12-14
PCT/US2001/009991 WO2001072295A2 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
CA2404233A1 true CA2404233A1 (en) 2001-10-04

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002404233A Abandoned CA2404233A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (cs)
AU (1) AU2001261007A1 (cs)
CA (1) CA2404233A1 (cs)
CZ (1) CZ20023567A3 (cs)
HU (1) HUP0500345A2 (cs)
PL (1) PL366626A1 (cs)
WO (1) WO2001072295A2 (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
EP1516049A4 (en) * 2001-05-11 2006-01-11 Corixa Corp COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF LUNG CANCER
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US7718787B2 (en) * 2002-10-18 2010-05-18 Lg Life Sciences Limited Gene families associated with cancers
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
WO2004055183A2 (en) * 2002-12-17 2004-07-01 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
CN1761680A (zh) 2002-12-26 2006-04-19 武田药品工业株式会社 肿瘤迁移抑制素衍生物及其用途
US7625869B2 (en) 2004-06-25 2009-12-01 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
JP2007263896A (ja) * 2006-03-29 2007-10-11 Univ Nagoya 肺癌患者の術後予後予測のための生物マーカー及びその方法
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
JP5648261B2 (ja) * 2006-12-20 2015-01-07 東レ株式会社 癌の検出方法
AU2009278386B2 (en) 2008-08-05 2015-05-21 Toray Industries, Inc. Pharmaceutical composition for treatment and prevention of cancers
PT2325648E (pt) * 2008-08-05 2014-06-24 Toray Industries Método para detetar cancro
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
RU2532105C2 (ru) 2008-10-22 2014-10-27 Онкотерапи Сайенс, Инк. Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины
WO2011096517A1 (ja) 2010-02-04 2011-08-11 東レ株式会社 癌の治療及び／又は予防用医薬組成物
PT2532366T (pt) 2010-02-04 2016-12-20 Toray Industries Composição farmacêutica para o tratamento e/ou prevenção de cancro
US9115200B2 (en) 2010-02-04 2015-08-25 Toray Industries, Inc. Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1
MX340017B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
ES2540858T3 (es) 2010-02-04 2015-07-14 Toray Industries, Inc. Composición farmacéutica para el tratamiento y/o la prevención de cáncer
RU2624029C2 (ru) 2010-02-04 2017-06-30 Торэй Индастриз, Инк. Лекарственный препарат для лечения и/или профилактики рака
CN103717238B (zh) 2011-08-04 2016-10-12 东丽株式会社 胰癌的治疗和/或预防用药物组合物
PT2740796T (pt) 2011-08-04 2017-07-26 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
MX348577B (es) 2011-08-04 2017-06-20 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
DK2740794T3 (en) 2011-08-04 2018-06-14 Toray Industries PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION
US9796775B2 (en) 2011-08-04 2017-10-24 Toray Industries, Inc. Method for detecting pancreatic cancer
CN103717737B (zh) 2011-08-04 2015-06-10 东丽株式会社 癌的治疗和/或预防用药物组合物
RU2624049C2 (ru) 2011-08-04 2017-06-30 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и профилактики злокачественной опухоли
AU2013223147B2 (en) 2012-02-21 2017-10-05 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
HUE044611T2 (hu) 2012-02-21 2019-11-28 Toray Industries Gyógyászati készítmény rák kezelésére
EP2818481B1 (en) 2012-02-21 2019-08-07 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
JP6187256B2 (ja) 2012-02-21 2017-08-30 東レ株式会社 癌の治療及び／又は予防用医薬組成物
CA2869123C (en) 2012-03-30 2021-03-16 Toray Industries, Inc. Pharmaceutical composition comprising anti-caprin-1 antibodies for the treatment of gallbladder cancer
WO2013147169A1 (ja) 2012-03-30 2013-10-03 東レ株式会社 肝臓癌の治療及び／又は予防用医薬組成物
HUE043162T2 (hu) 2012-07-19 2019-08-28 Toray Industries Eljárás rák detektálására
KR102056137B1 (ko) 2012-07-19 2019-12-16 도레이 카부시키가이샤 암의 검출 방법
DK3031826T3 (en) 2013-08-09 2018-12-17 Toray Industries Pharmaceutical composition for the treatment and / or prevention of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1187915A2 (en) * 1999-04-02 2002-03-20 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001253594A1 (en) * 2000-04-17 2001-10-30 Pharmacia And Upjohn Company Novel g protein-coupled receptors
WO2001083553A2 (en) * 2000-05-03 2001-11-08 Pharmacia & Upjohn Company G protein-coupled receptors
US20020040127A1 (en) * 2000-06-09 2002-04-04 Yuqiu Jiang Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
AU2001261007A1 (en) 2001-10-08
PL366626A1 (en) 2005-02-07
CZ20023567A3 (cs) 2003-11-12
HUP0500345A2 (hu) 2005-07-28
JP2004526401A (ja) 2004-09-02
WO2001072295A2 (en) 2001-10-04
WO2001072295A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
CA2404233A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US7585506B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
CA2411278A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
US20030118599A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20080219990A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002092001A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2003037267A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001077168A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002039885A2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20030069180A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
JP2004508812A (ja) 乳癌の治療および診断のための組成物および方法
EP1319069B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1351967B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001094409A2 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2002012331A2 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2003029468A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20040033230A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
US20060083749A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
US20020110563A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20020156011A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CA2537555A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1268797A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
ZA200209365B (en) Compositions and methods for the therapy and diagnosis of breast cancer.

Legal Events

Date Code Title Description
FZDE Discontinued